Share

April 02, 2013; 80 (14) Article

Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution

Lucy Matthews, Rita Marasco, Mark Jenkinson, Wilhelm Küker, Sebastian Luppe, Maria Isabel Leite, Antonio Giorgio, Nicola De Stefano, Neil Robertson, Heidi Johansen-Berg, Nikos Evangelou, Jacqueline Palace
First published March 13, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182887957
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1804

Share

Article Information

vol. 80 no. 14 1330-1337
DOI: 
https://doi.org/10.1212/WNL.0b013e3182887957
PubMed: 
23486868
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 12, 2012
  • Accepted December 12, 2012
  • First Published March 13, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Lucy Matthews, MRCP,
    2. Rita Marasco, MD,
    3. Mark Jenkinson, DPhil,
    4. Wilhelm Küker, PhD,
    5. Sebastian Luppe, MD,
    6. Maria Isabel Leite, DPhil,
    7. Antonio Giorgio, MD, PhD,
    8. Nicola De Stefano, MD, PhD,
    9. Neil Robertson, DM,
    10. Heidi Johansen-Berg, DPhil,
    11. Nikos Evangelou, DPhil and
    12. Jacqueline Palace, DM
  1. Lucy Matthews, MRCP,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Medical Research Council UK (G0901996) funded Clinical Research Training Fellowship. From May 2010-July 2012.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Rita Marasco, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Mark Jenkinson, DPhil,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH (USA), U54 MH091657 Human Connectome Project, co- applicant, 2010-2015 (2) NERC (UK), NE/I00680X/1, co-applicant, 2011-2014 (3) EPSRC (UK), EP/F05727X/1, postdoctoral scientist, 2009-2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. (1) FSL (FMRIB Software Library), ISIS Innovation and the University of Oxford, 2010-2012

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Wilhelm Küker, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neuroradiology, since 2010, editorial board member

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Sebastian Luppe, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Maria Isabel Leite, DPhil,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Have received speaker honoraria from Biogen Idec, Japan. Have received limited funding for travel to conferences from Biogen Idec and Novartis.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Antonio Giorgio, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Nicola De Stefano, MD, PhD,
    9. Scientific Advisory Boards:

    1. Prof. N. De Stefano serves on scientific advisory boards for Merck- Serono.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expense refunds from Teva and Merck-Serono.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Honoraria for lectures from Teva, BioMS, Biogen-Idec, Bayer Schering Pharma and Merck-Serono.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Neil Robertson, DM,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Neurology, Journal club editor May 2012 to current

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Multiple Sclerosis Society of Great Britain and Northern Ireland

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Heidi Johansen-Berg, DPhil,
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Diffusion MRI: from quantitative measurement to in-vivo neuroanatomy, Elsevier, 2009

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Nikos Evangelou, DPhil and
    12. Scientific Advisory Boards:

    1. member of advisory board for Bayer- schering,Serono and Novartis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. received funding attending conference from Bayer- Schering, Merck Serono and Novartis

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funded by HEFCE

    Research Support, Academic Entities:

    1. Received institutional support from the Nottingham University Hospital charity and NUH research and development department.

    Research Support, Foundations and Societies:

    1. Multiple sclerosis Of great britain and northern Ireland C-014

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Jacqueline Palace, DM
    13. Scientific Advisory Boards:

    1. UK advisory board participant: 1) Merck Serono 2) Bayer Schering Pharma 3) Biogen Idec 4) Teva Pharmaceutical Industries Ltd. 5) Novartis Pharmaceuticals UK Ltd. 6) Sanofi-Aventis

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Support for attending ECTRIMS Merck Serono 2008 and 2009

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. In addition to advisory committees, consultant for: Ono Pharmaceuticals Ltd. Chugai Pharma Ltd. CI Consulting

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Department of Health Risk Sharing Scheme, Clinical Coordinator since 2002

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Nuffield Department of Clinical Neurosciences (L.M., R.M., M.J., W.K., M.I.L., H.J.-B., J.P.), University of Oxford; Institute of Psychological Medicine and Clinical Neurosciences (S.L., N.R.), University of Cardiff; Department of Neurological and Behavioural Sciences (A.G., N.D.S.), University of Siena; and Faculty of Medicine & Health Sciences (N.E.), University of Nottingham, UK.
  1. Correspondence to Dr. Matthews: lucy.matthews{at}ndcn.ox.ac.uk
View Full Text

Article usage

Article usage: March 2013 to December 2022

AbstractFullPdfSource
Mar 2013238076Highwire
Apr 20132247110213Highwire
May 20133693453Highwire
Jun 20131573136Highwire
Jul 20131162128Highwire
Aug 2013762015Highwire
Sep 201373014Highwire
Oct 2013147016Highwire
Nov 2013117013Highwire
Dec 20139257Highwire
Jan 20148049Highwire
Jan 201406231pmc
Feb 20145343Highwire
Mar 20145896Highwire
Apr 20144044Highwire
May 20144297Highwire
Jun 20144074Highwire
Jul 20145644Highwire
Aug 20145953Highwire
Sep 201469119Highwire
Oct 20146526Highwire
Nov 20146246Highwire
Dec 20147443Highwire
Jan 201556410Highwire
Jan 201502622pmc
Feb 20158057Highwire
Feb 201504134pmc
Mar 20159969Highwire
Mar 201504428pmc
Apr 201579102Highwire
Apr 201505127pmc
May 201569102Highwire
May 201506341pmc
Jun 20155647Highwire
Jun 201504121pmc
Jul 20156733Highwire
Jul 201504024pmc
Aug 20158012Highwire
Aug 201503416pmc
Sep 20156202Highwire
Sep 20150249pmc
Oct 20156145Highwire
Oct 201504826pmc
Nov 20157715Highwire
Nov 201504723pmc
Dec 20158841Highwire
Dec 201505135pmc
Jan 20168534Highwire
Jan 201605328pmc
Feb 20166648Highwire
Feb 20160258pmc
Mar 20164015Highwire
Mar 201603515pmc
Apr 20163535Highwire
Apr 201602214pmc
May 20163311Highwire
May 201603222pmc
Jun 20161443Highwire
Jun 201602718pmc
Jul 20162323Highwire
Jul 201609120pmc
Aug 20162144Highwire
Aug 201603824pmc
Sep 20162722Highwire
Sep 201603217pmc
Oct 20164411Highwire
Oct 201603621pmc
Nov 20162131Highwire
Nov 201603114pmc
Dec 20162101Highwire
Dec 201602614pmc
Jan 20174176Highwire
Jan 201705521pmc
Feb 20171923Highwire
Feb 201704618pmc
Mar 20172611Highwire
Mar 201703610pmc
Apr 20172213Highwire
Apr 2017102828pmc
May 20172133Highwire
May 2017184144pmc
Jun 20172824Highwire
Jun 201773031pmc
Jul 20171304Highwire
Jul 2017183739pmc
Aug 20171101Highwire
Aug 2017134041pmc
Sep 20171111Highwire
Sep 201794249pmc
Oct 20172311Highwire
Oct 201793236pmc
Nov 20171630Highwire
Nov 2017145152pmc
Dec 20171576Highwire
Jan 20183621Highwire
Feb 201818124Highwire
Mar 201839121Highwire
Apr 20183174Highwire
Apr 2018104041pmc
May 201847153Highwire
Jun 20181861Highwire
Jun 2018133636pmc
Jul 20183130Highwire
Aug 20185712Highwire
Aug 2018194747pmc
Sep 20183131Highwire
Oct 20182462Highwire
Nov 20183321Highwire
Dec 20183810Highwire
Jan 20193842Highwire
Feb 20191940Highwire
Mar 20192910Highwire
Apr 20194443Highwire
May 20194933Highwire
Jun 20194000Highwire
Jul 20193521Highwire
Aug 20193231Highwire
Sep 20193001Highwire
Oct 20195453Highwire
Nov 20194411Highwire
Dec 20194123Highwire
Jan 20203721Highwire
Feb 20202452Highwire
Mar 20204832Highwire
Apr 20204431Highwire
May 20203401Highwire
Jun 20203342Highwire
Jul 20203343Highwire
Aug 20203432Highwire
Sep 20204531Highwire
Oct 20202810Highwire
Nov 20205021Highwire
Dec 20204530Highwire
Jan 20213575Highwire
Feb 20215234Highwire
Mar 20215742Highwire
Apr 20215651Highwire
May 20214882Highwire
Jun 20213231Highwire
Jul 20214571Highwire
Aug 20215120Highwire
Sep 20214250Highwire
Oct 20214653Highwire
Nov 20216062Highwire
Dec 20213831Highwire
Jan 20224000Highwire
Feb 20227763Highwire
Mar 20229802Highwire
Apr 20228570Highwire
May 20224822Highwire
Jun 20224848Highwire
Jul 20224921Highwire
Aug 20224720Highwire
Sep 20222821Highwire
Oct 20227203Highwire
Nov 20223251Highwire
Dec 20224151Highwire

Cited By...

Letters: Rapid online correspondence

  • 'Dawson's fingers' and Neuromyelitis Optica
    • Ilya Kister, Neurologist, NYU School of Medicine, NY
    • Ilya Kister, Yulin Ge, Joseph Herbert (New York, USA); Tim Sinnecker, Jens Wuerfel, Friedemann Paul (Berlin, Germany)
    Submitted May 07, 2013
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me